Articles On Memphasys

Title	Source	Codes	Date
Medtech needs more than a TGA tick to hit the big $$$ The announcement lands just before markets open, ‘the TGA has approved our device’; the buy orders begin to pile up and the pre-open share price begins to surge. But while a nod from Australia’s drug and device regulator, the Therapeutic Go...	Stockhead	MEM	5 years ago
Memphasys – The Business Of IVF Treatments ShareCafeMemphasys – The Business Of IVF Treatments Memphasys – The Business Of IVF TreatmentsCompany News	ShareCafe	MEM	5 years ago
Health Kick Podcast: Memphasys is electro-shocking sperm into better IVF performance Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the microscope and picking up the microphone for another instalment of The Health Kick Podcast. In this episode Tim chats with Alison Coutts, executive chair of Memp...	Stockhead	MEM	5 years ago
Health: Compumedics wins FDA approval for its brain scanners, leaps 20pc Another ASX small cap has won the blessing of the Food and Drug Administration (FDA) for its products enter the US market. This morning it was Compumedics (ASX:CMP). Its signature product, the Orion LifeSpan Magnetoencephalography single De...	Stockhead	MEM	5 years ago
9 of the most interesting biotech bosses in the game: part 2 You don’t need a PhD to run a biotech, but sometimes it helps, as these companies deal in one of the most complicated mysteries still to be solved today: the human body. Biotech CEOs and chairs tend to be the cross-over scientists. However,...	Stockhead	MEM	5 years ago
Dr Boreham’s Crucible: MedAdvisor could cure what ails it by shelving its expansion plans Did the doc say to take one pill twice daily, or two tablets once daily? When it comes to correct medication, it’s easy to get it wrong. Because of misreading instructions, forgetfulness, laziness or nasty side effects Australians aren’t es...	Stockhead	MEM	5 years ago
Dr Boreham’s Crucible: Memphasys now feeling the investor love for its IVF tech Did you know that a hard-working stallion ejaculates 100 times more sperm than the average bloke? Given a virile, but weary, thoroughbred can service hundreds of mares in a breeding season, that’s just as well. But even the most virile of t...	Stockhead	MEM	5 years ago
Hidden gems: These microsectors on the ASX have gained the most in 2019 This year has been a positive one for ASX small caps. According to Bloomberg, the average small cap has gained just under 5 per cent and some of the major sectors have seen double digit percentage gains. One example is the health sector whi...	Stockhead	MEM	6 years ago
Four Health Care Stocks Under Discussion – MEM, ONE, BIT, IME Australian Health Care is a dynamic sector with a potential to generate significant profits in the least amount of time, something, what investors eye for, while pouring cash in Stocks. In this article we will be digging into four Health Ca...	Kalkine Media	MEM	6 years ago
Rise & Shine: What you need to know before the ASX opens On Stockhead today: the three biggest opportunities for digital transformation in pharma, why it’s time to get excited about cobalt again, the top 10 stocks that doubled (and even tripled) in 24 hours and the stocks investors are shorting r...	Stockhead	MEM	6 years ago

Articles On Memphasys (ASX:MEM)